A novel mutation in two cousins with guanidinoacetate methyltransferase (GAMT) deficiency presented with autism

No Thumbnail Available

Date

2019

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Guanidinoacetate methyltransferase (GAMT) deficiency is a rare autosomal recessive disorder of creatine biosynthesis. Here, we report 9 and 10-year-old cousins with GAMT deficiency caused by a novel mutation who both exhibited neurodevelopmental retardation, seizures, behavioral problems, and autism that began during early infancy. The patients were diagnosed as having only autism and followed for years without a specific diagnosis although they had very low levels of serum creatinine for several times. A novel nonsense mutation in the GAMT gene that caused cessation of synthesis of the protein encoded by this gene was identified in these patients. GAMT deficiency is a treatable inborn error of metabolism and should be considered for all patients with hypotonia, developmental delay, seizures and autism, particularly if low serum creatinine levels are observed.

Description

Keywords

creatine deficiency syndromes, guanidinoacetate methyltransferase, autism, epilepsy

Citation

Endorsement

Review

Supplemented By

Referenced By